This article explains recent research findings on the role of soluble epoxide hydrolase (sEH) in nicotine-induced arterial stiffness. It highlights how sEH deletion can mitigate vascular damage caused by smoking.
The study emphasizes the potential of targeting sEH as a therapeutic approach to prevent or reduce arterial stiffness and related cardiovascular issues in smokers.